[ Price : $8.95]
FDA grants MeiraGTx Holdings a regenerative medicine advanced therapy designation for gene therapy AAV-GAD and its use for treatin...[ Price : $8.95]
FDA prepares to begin negotiation sessions in September to reauthorize the Prescription Drug User Fee Act, which expires 9/2027.[ Price : $8.95]
FDA commissioner Marty Makary says discussions are continuing with Novavax on its BLA to convert a 2022 emergency use authorizatio...[ Price : $8.95]
Paradigm Therapeutics plans an NDA submission in the second half of this year for Zorblisa (SD-101), as a topical whole-body treat...[ Price : $8.95]
FDA approves a Teal Health PMA for the Teal Wand, the first at-home vaginal sample, self-collection device for cervical cancer scr...[ Price : $8.95]
The FDA Office of Inspections and Investigations ombudsman program calls for establishing a dedicated Web page as a stakeholder ed...[ Price : $8.95]
FDA approves an Orchestra BioMed IDE to begin a pivotal clinical trial evaluating its next generation Virtue Sirolimus-AngioInfusi...[ Price : $8.95]
FDA grants Italfarmaco a fast track designation to givinostat for treating patients with polycythemia vera, a rare hematologic can...